Eterna Therapeutics announced the appointment of Dorothy Clarke to its Board of Directors. Ms. Clarke held various leadership positions at Johnson & Johnson over 20 years across the company’s pharmaceutical, medical devices & diagnostics, and consumer sectors.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on ERNA:
- Eterna Therapeutics Announces Initiation of Development Activities for Hypoimmune Pluripotent Cell Line for Neurology Indications Under Partnership With Lineage Cell Therapeutics
- Eterna Therapeutics Appoints Biopharma Industry Veteran Dorothy Clarke to Board of Directors
- Eterna files to sell 16.75M shares of common stock for holders
- Eterna completes $8.7M convertible debt financing
- Eterna appoints Binder, Wagner to board of directors
